Skip header and navigation

14 records – page 1 of 1.

Date Research Question / Title Unique ID Research Team
May 22, 2020 In similar jurisdictions experiencing the COVID-19 pandemic, what is the proportion of patients receiving non-invasive ventilation versus those receiving intermittent mandatory ventilation? EOC052102 RR EOC
June 2, 2020 What proportion of healthcare workers are rt-PCR positive and IgM or IgG positive? [Update] LAB040802v3 RR Laboratory
November 25, 2020 Are probiotics effective for prevention or therapy of respiratory tract infections in all ages? EOC111201 RR EOC
January 13, 2021 What are the outcomes of ECMO and COVID, particularly in small centers? EOC011101 RR EOC
February 27, 2021 What is the final disposition of post-COVID patients who require chronic ventilation in the ICU? CC011101 RR Critical Care
April 6, 2021 How to deliver remote ICU care for COVID-19 patients to avoid/prevent transfer from smaller communities to tertiary care hospitals CC210301 RR Critical Care
April 23, 2020 What sampling method is most appropriate for population testing? LAB042201 RR Laboratory
April 25, 2020 What frequency of repeat population screening will be required? LAB042202 RR Laboratory
April 28, 2020 What is the sensitivity and specificity of screening checklists and temperature checks for detecting the presence of COVID-19 in individuals? PH042401 RR Public Health
May 25, 2020 What factors can be used to identify negative PCR tests that are ‘false negatives’? EOC052101 RR EOC
May 19, 2020 What is the relationship between antibody development and viral shedding and infectiousness? [Update] LAB041601v2 RR Laboratory
October 7, 2021 What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population? EOC210902 RR EOC
January 12, 2022 In real world settings, what is the validity of Rapid Antigen Tests (RATs) in identifying SARS-CoV-2 and how well do they predict disease? EOC211201 RR EOC
April 21, 2021 What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? EOC210302 RR EOC

14 records – page 1 of 1.